Sign in to continue:

Tuesday, April 7th, 2026

NextPlat Corp Announces Amendments to Certificate of Incorporation and Fiscal Year Changes in Latest SEC Filing





NextPlat Corp Announces 1-for-10 Reverse Stock Split

NextPlat Corp Announces 1-for-10 Reverse Stock Split Effective April 13, 2026

Key Points for Investors

  • Reverse Stock Split Announced: NextPlat Corp will implement a 1-for-10 reverse stock split, effective prior to market open on April 13, 2026.
  • Share Reduction: The number of outstanding common shares will be reduced from approximately 26.9 million to about 2.7 million.
  • No Change in Par Value or Authorized Shares: The par value remains at \$0.0001 per share, and the number of authorized shares stays at 50 million.
  • Trading Symbol Unchanged: The ticker symbol “NXPL” will continue to be used. The new CUSIP number for post-split common stock is 68557F308.
  • No Fractional Shares: Cash will be paid in lieu of fractional shares, based on the closing price at the date the split becomes effective.
  • Adjustments to Equities and Warrants: All outstanding stock options, warrants, and shares reserved under the equity compensation plan will be adjusted proportionally.
  • Company Profile Update: NextPlat continues to operate in e-Commerce, communications, and healthcare, including through its subsidiary, Progressive Care.

Detailed Analysis

On April 2, 2026, NextPlat Corp filed an amended and restated certificate of incorporation with the Secretary of State of Nevada to effect a 1-for-10 reverse stock split. This corporate action, approved by the Board of Directors, aims to consolidate every 10 issued and outstanding shares of common stock into one share, with no change to the nominal par value of \$0.0001 per share. The effective time for the reverse split is set for 12:01 AM Eastern Time on April 13, 2026.

Implications for Shareholders

  • Outstanding Shares: Post-split, the number of outstanding common shares will drop from ~26.9 million to approximately 2.7 million. This significant reduction may impact trading liquidity and could influence the share price by increasing the per-share value, a common effect of reverse splits designed to bolster compliance with minimum bid price requirements for continued listing on the Nasdaq Capital Market.
  • Fractional Shares: Shareholders will not receive fractional shares. Instead, they will be compensated in cash for any fractions, calculated by multiplying such fraction by the closing price of the common stock on the date the split is effective.
  • Equity Awards and Warrants: All outstanding stock options and warrants, as well as shares reserved under the equity compensation plan, will be adjusted to reflect the 1-for-10 ratio. The exercise price for these instruments will increase proportionally, while the number of shares that can be acquired upon exercise will decrease.
  • Unchanged Share Structure: The total number of authorized shares will remain at 50 million, providing the company continued flexibility for future capital raising or corporate actions.
  • Symbol and CUSIP: The trading symbol “NXPL” remains unchanged, but post-split shares will have a new CUSIP (68557F308). The warrants continue under the symbol “NXPLW.”

Price Sensitive Information

The implementation of the reverse stock split is a material event with the potential to affect NextPlat Corp’s share price. Reverse splits are often used to maintain exchange listing requirements, improve the perception of the stock price, and attract new institutional investors who may have minimum price thresholds. While the split does not change the company’s overall market capitalization immediately, the reduced share count will make each share represent a greater ownership stake, which can result in higher volatility and price movement.

Shareholders should also note the company’s ongoing operations in e-Commerce and healthcare and its strategy to expand through acquisitions and partnerships, as outlined in the accompanying press release. The company’s subsidiary, Progressive Care, continues to provide pharmacy and healthcare data management services in the U.S., in addition to its global e-commerce communications division.

Financial Reporting Impact

In connection with the reverse split, NextPlat disclosed the pro forma impact on its net loss per share and weighted average shares outstanding for fiscal years 2024 and 2025. For example, the basic weighted average common shares outstanding will decrease from 26,535,000 (pre-split) to 2,653,000 (post-split) for 2025, and from 20,614,000 to 2,061,000 for 2024. Basic and diluted loss per share will increase proportionally (e.g., basic loss per share for 2025 will go from \$(0.44) pre-split to \$(4.41) post-split).

What Investors Should Watch

  • Share price may experience volatility around the effective date.
  • Monitor communications from the company and your broker regarding the handling of fractional shares.
  • The reverse split may attract or deter certain investors based on the new share price level and float.
  • Watch for any subsequent corporate actions or financial results that may follow the reverse split.

Contact and Additional Information

For investor relations, contact:
Michael Glickman
MWGCO, Inc.
Phone: 917-397-2272
Email: [email protected]

Disclaimer


This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. Investors should conduct their own due diligence and consult with financial advisors before making investment decisions. The information herein is based on publicly available filings as of April 2026 and is subject to change without notice.




View NextPlat Corp Historical chart here



   Ad